C19ORF5 is a homologue of microtubule-associated protein MAP1B that interacts with natural paclitaxel-like microtubule stabilizer and candidate tumor suppressor RASSF1A. Although normally distributed throughout the cytosol, C19ORF5 specifically associates with microtubules stabilized by paclitaxel or RASSF1A. At sufficiently high concentrations, C19ORF5 causes mitochondrial aggregation and genome destruction (MAGD). The accumulation on hyperstabilized microtubules coupled to MAGD has been proposed to mediate tumor suppression by the taxoid drug family and RASSF1A. Here, we show that the C-terminus of C19ORF5 (C19ORF5C) interacts with mitochondria-associated DNA binding protein, LRPPRC, in liver cells. Like LRPPRC, C19ORF5 also binds DNA with an affinity and specificity sufficient to be of utility in DNA affinity chromatography to purify homogeneous recombinant C19ORF5C from bacterial extracts. Homogeneous C19ORF5 exhibited no intrinsic DNase activity. Deletion mutagenesis indicated that C19ORF5 selectively binds double stranded DNA through its microtubule binding domain. These results suggest C19ORF5 as a DNA binding protein similar to microtubule-associated proteins tau and MAP2.
KeywordsAneuploidy; Apoptosis; DNA binding; LRPPRC; MAP1B; Microtubule-associated proteins; Mitochondria; Mitotic spindle; Paclitaxel; RASSF1A; VCY2IP1 C19ORF5 is a multifunctional sequence homologue of microtubule-associated protein MAP1B that interacts with the normally mitochondria-associated paclitaxel-like microtubule stabilizer and candidate tumor suppressor RASSF1A [1][2][3][4][5]. Isoform-specific epigenetic silencing of RASSF1A (3p21.3) by promoter-specific CpG-island hypermethylation occurs at high frequency in human tumors [6][7][8]. While normally distributed throughout the cytosol, C19ORF5 accumulates on hyperstabilized microtubules induced by either paclitaxel or RASSF1A [2][3][4]. In addition to these functions, when C19ORF5 accumulates in cells, it causes a unique form of cell death characterized by concentration on mitochondria, followed by an intense perinuclear aggregation of mitochondria resulting in gross degradation of genomic DNA within the aggregates. This cell death related process has been described as mitochondrial aggregation and genome destruction (MAGD), and suggested to mediate tumor suppression by the taxoid drug family and RASSF1A in response to catastrophic In addition to mitochondria-associated RASSF1 iso-forms, a yeast two-hybrid interaction screen revealed that C19ORF5 potentially interacts with several other mitochondriaassociated proteins [1]. One of the interactions was with LRPPRC (leucine-rich PPR-motif containing protein, AAA67549) [1,9], a nucleic acid binding protein [10,11] comprised of modular domains homologous to proteins involved in cytoskeletal dynamics, nucleocytosolic shuttling, and chromosome activity [9]. Here, we confirmed that C19ORF5 interacts with LRPPRC in mammalian cells. Since LRPPRC [10][11][12] and other microtubuleassociated proteins (MAP2 and tau) [13,14] have be...